Late divergence of survival curves in cancer immunotherapy trials: interpretation and implications.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 10, p. 1547, doi. 10.1007/s00262-013-1458-y
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2013 AND VI 62 AND IP 10
Results: 10
1
2
Mast cells expressing interleukin 17 in the muscularis propria predict a favorable prognosis in esophageal squamous cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 10, p. 1575, doi. 10.1007/s00262-013-1460-4
- By:
- Publication type:
- Article
3
Efficacy of postoperative adjuvant transfusion of cytokine-induced killer cells combined with chemotherapy in patients with colorectal cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 10, p. 1629, doi. 10.1007/s00262-013-1465-z
- By:
- Publication type:
- Article
4
Empty liposomes induce antitumoral effects associated with macrophage responses distinct from those of the TLR1/2 agonist PamCSK (BLP).
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 10, p. 1587, doi. 10.1007/s00262-013-1444-4
- By:
- Publication type:
- Article
5
Reduced expression of NGEP is associated with high-grade prostate cancers: a tissue microarray analysis.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 10, p. 1609, doi. 10.1007/s00262-013-1463-1
- By:
- Publication type:
- Article
6
Clinical-scale selection and viral transduction of human naïve and central memory CD8 T cells for adoptive cell therapy of cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 10, p. 1563, doi. 10.1007/s00262-013-1459-x
- By:
- Publication type:
- Article
7
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked is an immunogenic target of cancer stem cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 10, p. 1619, doi. 10.1007/s00262-013-1467-x
- By:
- Publication type:
- Article
8
Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGFβ1.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 10, p. 1637, doi. 10.1007/s00262-013-1466-y
- By:
- Publication type:
- Article
9
AE37 peptide vaccination in prostate cancer: a 4-year immunological assessment updates on a phase I trial.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 10, p. 1599, doi. 10.1007/s00262-013-1461-3
- By:
- Publication type:
- Article
10
Dendritic cell phenotype can be improved by certain chemotherapies and is associated with alterations to p21.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 10, p. 1553, doi. 10.1007/s00262-013-1456-0
- By:
- Publication type:
- Article